Cargando…
Transparency and reporting characteristics of COVID-19 randomized controlled trials
BACKGROUND: In the context of the COVID-19 pandemic, randomized controlled trials (RCTs) are essential to support clinical decision-making. We aimed (1) to assess and compare the reporting characteristics of RCTs between preprints and peer-reviewed publications and (2) to assess whether reporting im...
Autores principales: | Kapp, Philipp, Esmail, Laura, Ghosn, Lina, Ravaud, Philippe, Boutron, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510360/ https://www.ncbi.nlm.nih.gov/pubmed/36154932 http://dx.doi.org/10.1186/s12916-022-02567-y |
Ejemplares similares
-
Assessment of transparency and selective reporting of interventional trials studying colorectal cancer
por: Pellat, Anna, et al.
Publicado: (2022) -
Outcomes in Registered, Ongoing Randomized Controlled Trials of Patient Education
por: Pino, Cécile, et al.
Publicado: (2012) -
Inadequate description of educational interventions in ongoing randomized controlled trials
por: Pino, Cécile, et al.
Publicado: (2012) -
Reporting of analyses from randomized controlled trials with multiple arms: a systematic review
por: Baron, Gabriel, et al.
Publicado: (2013) -
Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention
por: Ethgen, Morgane, et al.
Publicado: (2009)